Cervical Carcinoma
Oncology·MeSH: Uterine Cervical Neoplasms
Prevalence
64.2 / 100K
Incidence
11.5 / 100K/yr
5 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| LN-145 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) |
Phase 1(1)
| Drug | Company |
|---|---|
| ln-145 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Cervical Carcinoma?
BioSniper tracks 5 drugs in development for Cervical Carcinoma across 2 companies.
How many clinical trials target Cervical Carcinoma?
There are 5 clinical trials targeting Cervical Carcinoma tracked by BioSniper.
What is the prevalence of Cervical Carcinoma?
The estimated prevalence of Cervical Carcinoma is approximately 64.2 per 100,000 population.
Deep-dive into Cervical Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis